Why Penguin Solutions Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Penguin Solutions jumped 7.7% after beating Q4 revenue/EPS estimates and issuing above-consensus FY27 EPS guidance.
Stocks · News reference
B of A Securities Maintains Buy on Caribou Biosciences, Lowers Price Target to $5
B of A Securities analyst Alec Stranahan maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and lowers the price target from $6 to $5.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Levi Strauss, Constellation Brands and 3 Stocks to Watch Heading Into Wednesday
Stocks in focus: Levi Strauss and Applied Digital report earnings; Caribou halts programs; Constellation raises guidance; Richardson reports.
Caribou Biosciences (CRBU) Shares Fall 35% After Hours: Here's Why
Caribou Biosciences shares fall 35% after hours as the company weighs strategic alternatives and cuts two drug programs.
Caribou Biosciences shares are trading lower after the company announced it is exploring strategic alternatives.